arrow
返回
K

Kui Wang

naval medical university

28H指数
105论文数
4.2K被引数
收录论文 51
发表时间
err分享
err收藏
Altered Regional Brain Activity Underlying the Higher Postoperative Analgesic Requirements in Abstinent Smokers: A Prospective Cohort Study戒断期吸烟者术后镇痛需求更高的区域脑活动改变:一项前瞻性队列研究
err2026-01-21
err0
errOAAI
errWei, Kai; Tao, Kunming; Bi, Yanzhi; Miao, Xuerong; Xiao, Hongmei; Zhang, Yue; Qiu, Haibo; Zhu, Jiao; Chen, Qianbo; Shen, Ling; Xu, Huihong; Ma, Min; Hu, Li; Wang, Kui; Lu, Zhijie
err分享
err收藏
Perioperative pembrolizumab and lenvatinib for resectable hepatocellular carcinoma: Updated efficacy and safety results from the phase II NeoLEAP-HCC study围术期帕博利珠单抗联合仑伐替尼治疗可切除肝细胞癌:来自II期NeoLEAP-HCC研究的更新疗效和安全性结果
err2024-12-01
err1
PREAI
errWang, K.; Yang, N.; Xue, H.; Yang, Y-C.; Sun, H.; Zhu, X.; Chen, Y-J.; Kuang, M.; Ye, F.; Shen, S.; Huang, C.; Shen, Y.; Sun, Y-F.; Xue, F.; Liu, J.; Bai, S.; Yang, Z.; Zhou, J.; Fan, J.
err分享
err收藏
Transcriptomic Insights into Hub Genes, Immune Infiltration, and Candidate Drugs in Erosive Esophagitis
err2024-10-01
err0
errOAAI
errZhao, Ye; Chen, Xi; Huang, Yuhan; Zhang, Zhihan; Wang, Kui; Zou, Duowu; Ma, Teng
err分享
err收藏
YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axisYBX1通过AKT/β-catenin轴促进肝内胆管癌的干细胞性和顺铂不敏感性
err2024-04-27
err2
errOAAI
errShi, Xiaodong; Hu, Zhiliang; Bai, Shilei; Zong, Chen; Xue, Hui; Li, Yao; Li, Fengwei; Chen, Liangrui; Xuan, Jianbing; Xia, Yong; Wei, Lixin; Shen, Feng; Wang, Kui
err分享
err收藏
Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi-institutional analysis
err2024-03-20
err1
errOAAI
errFu, Jun; Zheng, Lifang; Tang, Shicuan; Lin, Kongying; Zheng, Shuguo; Bi, Xinyu; Wang, Jianming; Guo, Wei; Li, Fuyu; Wang, Jian; Wang, Kui; Li, Haitao; Zeng, Yongyi
err分享
err收藏
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study
err2024-02-16
err1
errOAAI
errLin, Kong-Ying; Zhang, Jian-Xi; Lin, Zhi-Wen; Chen, Qing-Jing; Luo, Liu-Ping; Chen, Jin-Hong; Wang, Kui; Tai, Sheng; Zhang, Zhi-Bo; Wang, Shi-Feng; Li, Jing-Dong; Wang, Kai; Zheng, Lu; Zheng, Si-Ming; Wu, Meng-Meng; Lin, Ke-Can; Yang, Tian; Zeng, Yong-Yi
err分享
err收藏
Final overall survival (OS) results of befotertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)
err2023-11-01
err0
PREAI
errLu, S.; Zhang, Y.; Zhang, G.; Zhou, J.; Cang, S.; Cheng, Y.; Wu, G.; Cao, P.; Lv, D.; Jian, H.; Chen, C.; Jin, X.; Tian, P.; Wang, K.; Jiang, G.; Chen, G.; Chen, Q.; Zhao, H.; Ding, C.; Ding, L.
err分享
err收藏
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
err2023-06-29
err10
PREAI
errLin, Kong-Ying; Lin, Zhi-Wen; Chen, Qing-Jing; Luo, Liu-Ping; Zhang, Jian-Xi; Chen, Jin-Hong; Wang, Kui; Tai, Sheng; Zhang, Zhi-Bo; Wang, Shi-feng; Zhang, Jin-Yu; You, Wu-Yi; Wang, Bin; You, Peng-Hui; Lin, Ke-Can; Yang, Tian; Zeng, Yong-Yi
err分享
err收藏
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma
err2023-06-22
err9
PREAI
errLei, Zhengqing; Ma, Weihu; Si, Anfeng; Zhang, Yuhua; Yang, Facai; Yu, Qiushi; Tang, Haolan; Xiao, Qianru; Zhou, Jiahua; Wang, Kui; Tang, Yufu; Han, Tao; Yin, Guowen; Chen, Jinhong; Liu, Xiufeng; Zhao, Hua; Yu, Decai; Luo, Tao; Wang, Qing; Yan, Maolin; Mao, Xianhai; Li, Jing; Wang, Kai; Li, Jingdong; Zeng, Yongyi; Ding, Dequan; Chen, Tingsong; Wu, Xiaofeng; Xia, Yongxiang; Wang, Kang; Guo, Weixing; Zhu, Guangyu; Gao, Shan; Hueser, Norbert; Lau, Wan Y.; Song, Tianqiang; Cheng, Shuqun; Shen, Feng; Cheng, Zhangjun
err分享
err收藏